The Novalung® System
for ECMO*

Designed to Provide Safety,
Simplicity, and Portability

Why the Novalung System?

The Novalung System's single integrated platform focuses on improving the delivery, duration, and impact of life-saving care. This technology is designed to oxygenate blood, remove CO2, and is a good option for ECMO-assisted cardiopulmonary resuscitation (ECPR), patients who need assistance weaning from cardiopulmonary bypass (CPB), and extracorporeal carbon dioxide removal (ECCO2R).


Designed to minimize emergent circuit changes


Intuitive user-interface designed to simplify workflow and save time


Designed to ease transport throughout the hospital

The Novalung System for ECMO


Click here to see our Oxygenator in action.

DP3 Pump Head

Click here to see our DP3 Pump Head in action.

Click on the Image Below to Learn More About the Novalung System

The Novalung System features a portable console, large screen, and 2 backup batteries.

The X-Lung Kit

The Novalung System includes the innovative X-Lung Kit, which provides extracorporeal gas exchange. The X-Lung Kit includes a membrane lung, DP3 pump head, and integrated pressure sensors.

Designed to Provide You With Safety and Simplicity

  • Proprietary x.ellence® heparin and albumin coating designed to provide hemocompatibility
  • DP3 pump with minimal prime volume and precise control during low- and high-flow delivery
  • Integrated pressure sensors and polymethylpentene (PMP) fiber technology designed for reduced risk of air aspiration, with built-in oxygenator, bubble trap, backup drive, and more

The Novalung System – Specifications

Every component of the Novalung System was engineered to support intensive care unit teams and their patients. Explore the innovative technologies that make this system a true game changer for critical patient care.


Features x.ellence® heparin coating designed to provide hemocompatibility for long-term applications. Includes polymethylpentene (PMP) fiber technology and line-integrated pressure sensors and bubble trap.

DP3 Pump Head

Diagonal pump designed to produce less hemolysis than other pumps.4 Back-up pump drive designed to reduce delays on therapy.

Control Panel and Power Supply

Intuitive user-interface, precise control, and back-up batteries providing 120-420 minutes of power.2

Integrated Pressure Sensors

Designed to save time and provide ease of use.

Product Ordering Information

Fresenius Medical Care has been a trusted partner of healthcare providers for years. The Novalung System is intended for patients with acute cardiopulmonary failure requiring veno-venous (VV), veno-arterial (VA), or ECMO-assisted cardiopulmonary resuscitation (ECPR) and was the first extracorporeal membrane oxygenation (ECMO) system cleared for >6 hours of therapy.

Please see the following product ordering information.

Support and Contact

Customer Service/Technical Service

for Customer Service
press 3, then for the
Novalung System press 2.

Contact Us for More Information

*ECMO, extracorporeal membrane oxygenation.


  1. Data on File.
  2. Novalung Console. Instructions for Use. Fresenius Medical Care North America; 2019. Item no. 38350277. Version: US_003_2019_08.
  3. Eckman PM, Katz JN, El Banayosy A, Bohula EA, Sun B, van Diepen S. Veno-Arterial Extracorporeal Membrane Oxygenation for Cardiogenic Shock: An Introduction for the Busy Clinician. Circulation. 2019;140(24):2019-2037. doi:10.1161/CIRCULATIONAHA.119.034512
  4. Fleck T, Benk C, Klemm R, et al. First serial in vivo results of mechanical circulatory support in children with a new diagonal pump. Eur J Cardiothorac Surg. 2013;44(5):828-835. doi:10.1093/ejcts/ezt427
  5. X-Lung Kit. Instructions for Use. Fresenius Medical Care North America; 2019. Item no: 8200733. Version: US_003_2019_08.


The Novalung System is indicated for long-term (>6 hours) respiratory/cardiopulmonary support that provides assisted extracorporeal circulation and physiologic gas exchange (oxygenation and CO2 removal) of the patient's blood in adults with acute respiratory failure or acute cardiopulmonary failure, where other available treatment options have failed, and continued clinical deterioration is expected or the risk of death is imminent. These may include:

  • Failure to wean from cardiopulmonary bypass following cardiac surgery in adult patients
  • ECMO-assisted cardiopulmonary resuscitation in adults

Caution: Federal (US) law restricts these devices to sale by or on the order of a physician.

Note: Read the Instructions for Use for safe and proper use of these devices. The Indications for Use for this device can be found at

© 2024 Fresenius Medical Care. All Rights Reserved. Fresenius Medical Care, the triangle logo, Novalung, X-Lung and x.ellence are trademarks of Fresenius Medical Care Holdings, Inc. or its affiliated companies. All other trademarks are the property of their respective owners. D/N US-Novalung-000003 Rev A 04/2024

Oxygenator Specifications5

DP3 Pump Head Specifications5

Novalung® Console and Power Supply Specifications2

Integrated Pressure Sensor Specifications5